Clinical Trial: Integrated Clinical Study of Traditional Chinese and Western Medicine for Refractory Rheumatoid Arthritis

U.S., July 23 -- ClinicalTrials.gov registry received information related to the study (NCT07721142) titled 'Integrated Clinical Study of Traditional Chinese and Western Medicine for Refractory Rheumatoid Arthritis' on March 26.

Brief Summary: To evaluate the efficacy and safety of Kunxian Capsule combined with Methotrexate and Tofacitinib in the treatment of difficult-to-treat rheumatoid arthritis through a multicenter, randomized, double-blind, placebo-controlled clinical trial, and to identify the therapeutic advantages of integrated Chinese and Western medicine for optimizing the clinical strategy of D2T RA.

Study Start Date: Oct. 15, 2025

Study Type: INTERVENTIONAL

Condition: Rheumatoid Arthritis (RA)

Intervention: DRUG: Kunxian...